Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcia Canto

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 10, 2008
Genetic and epigenetic alterations of familial pancreatic cancersKieran Brune, Seung-Mo Hong, Ang Li, et al.
Genes, Chromosomes & Cancer|February 4, 2012
The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesisRom S Leidner, Lakshmeswari Ravi, Patrick Leahy, et al.
Annals of Surgery|April 25, 2006
Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosisJordan M Winter, John L Cameron, Keith D Lillemoe, et al.
Endoscopy|January 25, 2020
Cryoballoon ablation for gastric pouch and/or outlet reduction in patients with weight regain post Roux-en-Y gastric bypassLea Fayad, Arvind J Trindade, Petros C Benias, et al.
Gastrointestinal Endoscopy|January 18, 2012
EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II studyJ Randolph Hecht, James J Farrell, Neil Senzer, et al.
Gastrointestinal Endoscopy|March 27, 2007
Interobserver agreement for EUS findings in familial pancreatic-cancer kindredsMark Topazian, Felicity Enders, Michael Kimmey, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 2, 2016
Predicting Barrett's Esophagus in Families: An Esophagus Translational Research Network (BETRNet) Model Fitting Clinical Data to a Familial ParadigmXiangqing Sun, Robert C Elston, Jill S Barnholtz-Sloan, et al.
Plos One|April 3, 2008
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical featuresFumiaki Sato, Zhe Jin, Karsten Schulmann, et al.
Plos Genetics|April 13, 2011
Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesisHector Alvarez, Joanna Opalinska, Li Zhou, et al.
Cancer Biology & Therapy|September 7, 2010
The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinomaAlvarez Hector, Elizabeth A Montgomery, Collins Karikari, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 10, 2008
Genetic and epigenetic alterations of familial pancreatic cancersKieran Brune, Seung-Mo Hong, Ang Li, et al.
Genes, Chromosomes & Cancer|February 4, 2012
The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesisRom S Leidner, Lakshmeswari Ravi, Patrick Leahy, et al.
Annals of Surgery|April 25, 2006
Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosisJordan M Winter, John L Cameron, Keith D Lillemoe, et al.
Endoscopy|January 25, 2020
Cryoballoon ablation for gastric pouch and/or outlet reduction in patients with weight regain post Roux-en-Y gastric bypassLea Fayad, Arvind J Trindade, Petros C Benias, et al.
Gastrointestinal Endoscopy|January 18, 2012
EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II studyJ Randolph Hecht, James J Farrell, Neil Senzer, et al.
Gastrointestinal Endoscopy|March 27, 2007
Interobserver agreement for EUS findings in familial pancreatic-cancer kindredsMark Topazian, Felicity Enders, Michael Kimmey, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 2, 2016
Predicting Barrett's Esophagus in Families: An Esophagus Translational Research Network (BETRNet) Model Fitting Clinical Data to a Familial ParadigmXiangqing Sun, Robert C Elston, Jill S Barnholtz-Sloan, et al.
Plos One|April 3, 2008
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical featuresFumiaki Sato, Zhe Jin, Karsten Schulmann, et al.
Plos Genetics|April 13, 2011
Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesisHector Alvarez, Joanna Opalinska, Li Zhou, et al.
Cancer Biology & Therapy|September 7, 2010
The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinomaAlvarez Hector, Elizabeth A Montgomery, Collins Karikari, et al.
Pageof 5